Lessons learned for the Independent Panel for Evidence for Action against AMR from previous international science panels: stakeholder views from the 2025 Lagos Workshop
by Dr. Kevin Outterson (co-author) in The Lancet Microbe
Point-of-care routine laboratory testing for patients with suspected viral hemorrhagic fevers
by Dr. Madeline DiLorenzo (co-author) in Antimicrobial Stewardship & Healthcare Epidemiology
Self-care strategies and interventions to address antimicrobial resistance: evidence review and recommendations for national programs, service providers, caregivers, and self-carers
by Dr. Rodgers Ayebare (co-author) in Frontiers in Public Health
Why Bundibugyo’s fight against Ebola relies on trust
commentary by Dr. Mosoka Fallah (co-author) in Nature Africa
Innate Immune Sensing of HIV Defective Provirus Transcripts Contributes to Chronic Inflammation
by Dr. Andrew Henderson (co-author) in The Journal of Immunology
Hepatitis C virus seroprevalence among people with sickle cell disease in Uganda: a cross-sectional study
by Dr. David Hamer (co-author) in Therapeutic Advances in Infectious Disease
The role of faith-based organizations in the pharmaceutical systems of low-and-middle-income countries – A scoping review
by Dr. Veronika Wirtz (co-author) in PLOS Global Public Health
Leveraging current capacity to address the high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in South Africa: Modelling potential costs and benefits of near point-of-care GeneXpert testing for STIs
by Dr. Brooke Nichols (co-author) in PLOS Global Public Health
Configurationally Locked Ridaifen-B Analogs as Potent Ebola Virus Entry Inhibitors
by Dr. Robert Davey (co-author) in Journal of Medicinal Chemistry
Beyond Cure: A Scoping Review of Post-Tuberculosis Long-Term Health Outcomes
by Dr. Pranay Sinha in Tropical Medicine and Infectious Disease